ARVO 2022 – New retinal findings with Imagine Eyes’ AO imaging
At ARVO 2022, users of Imagine Eyes’ adaptive optics (AO) imaging systems will present new clinical findings in several retinal diseases, myopia, as well as multiple sclerosis. They will report on cellular phenotypes, structure-function relations, and surgical outcomes assessed at the cellular level.
H2020 MERLIN project celebrates successful final review
At Imagine Eyes we are happy to announce the successful completion of our Horizon 2020 MERLIN project. We received a very…
i2eye meeting – Innovative Imaging in Eye Disease
Users of Imagine Eyes' adaptive optics retinal imaging systems will present 11 talks about phenotyping and monitoring of diseases in the retina...
Euretina 2021 – Progression rate of retinitis pigmentosa measured over 6 months
Researchers at the Lions Eye Institute present a longitudinal study that assessed the progression of RP with both OCT and rtx1...
Euretina 2021 – Retinal imaging beyond photoreceptor cells
Users of Imagine Eyes’ rtx1 adaptive optics retinal cameras will report a number of new and extraordinary explorations...
rtx1 users’ e-symposium 2021
Last week, Imagine Eyes held the first edition of the rtx1 users' e-symposium. Clinicians, researchers and ophthalmic photographers…
Clinical and animal findings with adaptive optics retinal cameras
In recent years, not only clinical investigators, but also animal researchers have increasingly adopted the rtx1 AO camera…
New video on adaptive optics retinal imaging
In a brief format, a new video shows how clinicians use the rtx1 Adaptive Optics Retinal Camera to reveal microscopic lesions…
ARVO 2021: Phenotyping at the cellular level in the retina
This year at ARVO 2021, users of Imagine Eyes’ rtx1 report clinical and animal findings in several diseases. They present new phenotype information at the cellular level in the retina, obtained with adaptive optics imaging.
Novel clinical findings with rtx1 got published
Published last month, 4 Adaptive Optics studies report novel findings in retinal diseases, diabetes, and in subjects with…